Expertise: Venture Capital, Venture Growth, VIPEs
Michael has 14 years of operational experience and six years investment banking experience in life science companies and has been with Abingworth since 2002. He is involved in executive chair roles and has recently become Executive Chairman at Paratek Pharmaceuticals. Michael’s directorships have included Avedro, Avila Therapeutics, InMediata, Supernus Pharmaceuticals and Valeritas.
He was formerly Vice Chairman of Corixa and was President and Chief Executive of Coulter Pharmaceuticals from 1996 until it merged into Corixa in 2000. Previously he was an early employee at Gilead Sciences where he spent eight years serving in various capacities, including Executive Vice President of Operations and CFO. Before joining Gilead, Michael was a Partner at Hambrecht & Quist, where he became Co-Head of Healthcare Investment Banking. Michael has a BS Degree in Commerce from the University of Virginia and qualified as a CPA before completing his MBA at Stanford University.